Transcutaneous Pulsed Radiofrequency in Migraine
- Conditions
- Migraine Disorders
- Interventions
- Other: Transcutaneous pulsed radiofrequency qurrent
- Registration Number
- NCT05499689
- Lead Sponsor
- Diskapi Teaching and Research Hospital
- Brief Summary
The aim of the investigator is to compare the efficacy of greater occipital nerve block and transcutaneous pulsed radiofrequency treatment in migraine.
- Detailed Description
Migraine is the second most common primary headache. Greater occipital nerve (GON) block is an effective method in the treatment of migraine. Transcutaneous pulsed radiofrequency (RF) therapy is used in the treatment of pain. However, its use in headaches is not widespread yet.
Investigator aimed to compare the efficacy of transcutaneous pulsed radiofrequency therapy applied through the GON trace and GON block therapy. A 60-patient study was designed. GON block was planned for 30 patients and transcutaneous pulsed RF was planned for 30 patients. The block will be applied once at the level of C2 vertebra with ultrasound.Transcutaneous pulsed RF will be applied twice, once a week, for 8 minutes.All patients will have pre-treatment migraine disability assessment score (MIDAS) scores filled. A headache diary will be provided to all patients. Frequency and severity of pain will be followed for 1 month. Pain intensity will be evaluated on the visual analog scale (VAS).
Investigator aimed to evaluate the efficacy of transcutaneous pulsed RF therapy, which is a noninvasive method, in migraine.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 60
- Chronic Migraine
- Other headaches will not accompany (tension-type headache, cluster...)
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Transcutaneous pulsed RF group Transcutaneous pulsed radiofrequency qurrent 30 patients who underwent greater occipital nerve pulsed radiofrequency GON block group Bupivacaine Hydrochloride 30 patients who underwent greater occipital nerve block
- Primary Outcome Measures
Name Time Method The Migraine Disability Assessment Test Baseline The MIDAS questionnaire is an important part of a package of educational, investigative, and therapeutic measures, and could play a major role in improving the care of patients with migraine and other types of headache.
- Secondary Outcome Measures
Name Time Method Visual analog scale (VAS) Baseline, Week 4 It is a scale that measures the severity of pain. Scored between ''0: no pain'' and ''10: worst pain'' .
Trial Locations
- Locations (1)
Diskapi Yildirim Beyazıt Teaching and Research Hospital
🇹🇷Ankara, Altındğ, Turkey